NKGen Biotech, Inc.

CIK 1845459 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for NKGen Biotech, Inc..

Recent SEC filings

FiledFormAccession number
Sep 2, 20268-K0001213900-26-096778
Jul 17, 20268-K0001213900-26-079235
Jun 2, 20268-K0001213900-26-064294
May 21, 20268-K0001213900-26-060160
May 4, 20268-K0001213900-26-051727
Apr 21, 20268-K0001213900-26-046267
Feb 26, 20268-K0001213900-26-020876
Feb 5, 20268-K0001213900-26-012879
Jan 26, 20268-K0001213900-26-007794
Jan 20, 202610-Q0001845459-26-000003
Jan 16, 20268-K0001213900-26-005260
Jan 9, 20268-K0001213900-26-003030
Oct 8, 202510-K0001845459-25-000004
Sep 29, 20258-K0001213900-25-093062
Sep 24, 20258-K0001213900-25-091112
Sep 9, 20258-K0001213900-25-085858
Jul 17, 202525-NSE0001354457-25-000685
Jul 17, 20258-K0001213900-25-065162
Jul 16, 20258-K0001213900-25-064774
Jun 20, 20258-K0001213900-25-055833
Jun 20, 20258-K0001213900-25-055833
Jun 2, 202540001104659-25-055325
Jun 2, 2025SCHEDULE 13D0001104659-25-055326
May 20, 20258-K0001213900-25-045648
May 15, 2025NT 10-Q0001213900-25-044178